MAYZENT vs VUMERITY

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 21, 2026·How we rate

Possible drug interaction. MAYZENT and VUMERITY are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	MAYZENT	VUMERITY
Rating	70/100	New
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	SIPONIMOD	DIROXIMEL FUMARATE
Manufacturer	Novartis	Biogen
Dosage forms	Tablet	Capsule
Drug class	—	—
Boxed warning	None	None
Treats	Chronic Progressive Multiple Sclerosis, Relapsing-Remitting Multiple Sclerosis	Demyelinating Diseases, Chronic Progressive Multiple Sclerosis, Relapsing-Remitting Multiple Sclerosis

mayzent vumerity

Rating

70/100

New

Pharmacy pays

—

Type

Active ingredient

SIPONIMOD

DIROXIMEL FUMARATE

Manufacturer

Novartis

Biogen

Dosage forms

Tablet

Capsule

Drug class

—

Boxed warning

None

Treats

Chronic Progressive Multiple Sclerosis, Relapsing-Remitting Multiple Sclerosis

Demyelinating Diseases, Chronic Progressive Multiple Sclerosis, Relapsing-Remitting Multiple Sclerosis

Frequently asked questions

What is the difference between Mayzent and Vumerity?

Mayzent contains Siponimod, while Vumerity contains Diroximel Fumarate — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.